Last €23.17 EUR
Change Today +0.03 / 0.13%
Volume 329.9K
As of 1:55 PM 08/20/14 All times are local (Market data is delayed by at least 15 minutes).

rhoen-klinikum ag (RHK) Snapshot

Open
€23.17
Previous Close
€23.14
Day High
€23.21
Day Low
€23.10
52 Week High
06/9/14 - €24.87
52 Week Low
09/10/13 - €17.25
Market Cap
3.2B
Average Volume 10 Days
481.4K
EPS TTM
€9.81
Shares Outstanding
138.2M
EX-Date
06/13/14
P/E TM
2.4x
Dividend
€0.25
Dividend Yield
1.08%
Current Stock Chart for RHOEN-KLINIKUM AG (RHK)

Related News

No related news articles were found.

rhoen-klinikum ag (RHK) Related Businessweek News

No Related Businessweek News Found

rhoen-klinikum ag (RHK) Details

RHÖN-KLlNlKUM Aktiengesellschaft provides healthcare services in Germany. As of April 30, 2014, the company had 10 hospitals in 5 locations and a total of 5,300 beds. It also had hospitals in Boizenburg, Cuxhaven, and Waltershausen-Friedrichroda. The company is headquartered in Bad Neustadt a.d. Saale, Germany.

rhoen-klinikum ag (RHK) Top Compensated Officers

Chairman of Management Board
Total Annual Compensation: €1.0M
Chief Financial Officer and Member of Managem...
Total Annual Compensation: €733.0K
Member of Management Board and Regional Direc...
Total Annual Compensation: €450.0K
Compensation as of Fiscal Year 2013.

rhoen-klinikum ag (RHK) Key Developments

Rhön-Klinikum AG Announces Earnings Results for the Six Months of 2014; Provides Earnings Guidance for the Financial Year of 2015

Rhön-Klinikum AG announced earnings results for the six months of 2014. The company’s revenues for this period are at EUR 959.1 million, earnings before interest, taxes, depreciation and amortisation (EBITDA) amount to EUR 1.35 billion due to the sales proceeds. As for the first quarter of the current financial year, the financial figures for the first six months were also significantly influenced by the sale to Fresenius/Helios of a total of 40 hospitals and associated facilities. The financial figures for the first six months reflect this extraordinary situation: the financial statement for the first two months of the year was drawn up with the full consolidation of the previous portfolio in its entirety while the reduced portfolio is included since March. Added to this are numerous primarily positive one-off effects but there are also burdens, both of which can generally be attributed to the transaction. The company expects revenues of EUR 1.06 billion to EUR 1.12 billion and earnings before interest, tax, depreciation and amortisation (EBITDA) of between EUR 145 million and EUR 155 million for the coming financial year 2015.

Braun Withdraws Lawsuit Against Amendment of Articles of Association Regarding '90%-Clause' of Rhön-Klinikum Aktiengesellschaft

Braun Holding GmbH & Co. KG notified the Rhön-Klinikum Aktiengesellschaft that it has withdrawn its lawsuit against the resolution of the general meeting of 12 June 2013 to abolish the qualified majority requirement of more than 90% for certain important resolutions of the general meeting in the article of association of the company. The company welcomes the withdrawal of the lawsuit by Braun. However, besides Braun three other plaintiffs have filed lawsuits against the Amendment. These lawsuits are still pending. The Amendment will only become effective upon registration in the commercial register. The commercial register has suspended the registration process due to the pending lawsuits.

Rhön-Klinikum AG Announces Earnings Results for the First Quarter of 2014; Confirms Earnings Guidance for the Year 2015

Rhön-Klinikum AG announced earnings results for the first quarter of 2014. For the quarter, the company’s revenues are at EUR 629.5 million while earnings before interest, taxes, depreciation and amortization (EBITDA) amount to EUR 1,488.0 million. The company confirmed earnings guidance for the year 2015. For the period, the company confirmed its outlook with revenues of EUR 1.06 billion to EUR 1.12 billion and earnings before interest, tax, depreciation and amortization (EBITDA) of between EUR 145 million and EUR 155 million for 2015, the first full financial year with the new corporate structure.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
RHK:GR €23.17 EUR +0.03

RHK Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for RHK.
View Industry Companies
 

Industry Analysis

RHK

Industry Average

Valuation RHK Industry Range
No financial data is available for RHK.
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact RHOEN-KLINIKUM AG, please visit www.rhoen-klinikum-ag.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.